In addition, ICC patients with a concentration of CEA ≤ 5 ng/mL and γ-GGT ≤ 60 U/L tended to carry FGFR2 fusion/rearrangement. The gene discussed is CEACAM5; the disease is intrahepatic cholangiocarcinoma.